Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands |
Total |
Common Stock Class A |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Retained Earnings |
| Beginning balance (in shares) at Dec. 28, 2023 |
|
106,738,000
|
|
|
|
| Beginning balance at Dec. 28, 2023 |
$ 1,930,990
|
$ 107
|
$ 513,060
|
$ 1,422
|
$ 1,416,401
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Stock-based compensation expense |
7,232
|
|
7,232
|
|
|
| Exercise of stock options (in shares) |
|
171,000
|
|
|
|
| Exercise of stock options |
3,854
|
|
3,854
|
|
|
| Issuance of common stock upon vesting of restricted stock units (in shares) |
|
184,000
|
|
|
|
| Shares issued under employee stock purchase plan (in shares) |
|
28,000
|
|
|
|
| Shares issued under employee stock purchase plan |
2,720
|
|
2,720
|
|
|
| Common stock redeemed for tax liability (in shares) |
|
(110,000)
|
|
|
|
| Common stock redeemed for tax liability |
(13,057)
|
|
(13,057)
|
|
|
| Other comprehensive (loss) gain, net of tax |
(970)
|
|
|
(970)
|
|
| Net income |
50,032
|
|
|
|
50,032
|
| Ending balance (in shares) at Mar. 28, 2024 |
|
107,011,000
|
|
|
|
| Ending balance at Mar. 28, 2024 |
1,980,801
|
$ 107
|
513,809
|
452
|
1,466,433
|
| Beginning balance (in shares) at Dec. 28, 2023 |
|
106,738,000
|
|
|
|
| Beginning balance at Dec. 28, 2023 |
1,930,990
|
$ 107
|
513,060
|
1,422
|
1,416,401
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Other comprehensive (loss) gain, net of tax |
(1,501)
|
|
|
|
|
| Net income |
158,388
|
|
|
|
|
| Ending balance (in shares) at Sep. 26, 2024 |
|
107,224,000
|
|
|
|
| Ending balance at Sep. 26, 2024 |
2,111,055
|
$ 107
|
536,238
|
(79)
|
1,574,789
|
| Beginning balance (in shares) at Mar. 28, 2024 |
|
107,011,000
|
|
|
|
| Beginning balance at Mar. 28, 2024 |
1,980,801
|
$ 107
|
513,809
|
452
|
1,466,433
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Stock-based compensation expense |
8,355
|
|
8,355
|
|
|
| Exercise of stock options (in shares) |
|
112,000
|
|
|
|
| Exercise of stock options |
1,588
|
|
1,588
|
|
|
| Issuance of common stock upon vesting of restricted stock units (in shares) |
|
13,000
|
|
|
|
| Common stock redeemed for tax liability (in shares) |
|
(3,000)
|
|
|
|
| Common stock redeemed for tax liability |
(470)
|
|
(470)
|
|
|
| Other comprehensive (loss) gain, net of tax |
(346)
|
|
|
(346)
|
|
| Net income |
56,666
|
|
|
|
56,666
|
| Ending balance (in shares) at Jun. 27, 2024 |
|
107,133,000
|
|
|
|
| Ending balance at Jun. 27, 2024 |
2,046,594
|
$ 107
|
523,282
|
106
|
1,523,099
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Stock-based compensation expense |
10,031
|
|
10,031
|
|
|
| Exercise of stock options (in shares) |
|
49,000
|
|
|
|
| Exercise of stock options |
769
|
|
769
|
|
|
| Issuance of common stock upon vesting of restricted stock units (in shares) |
|
18,000
|
|
|
|
| Shares issued under employee stock purchase plan (in shares) |
|
31,000
|
|
|
|
| Shares issued under employee stock purchase plan |
2,739
|
|
2,739
|
|
|
| Common stock redeemed for tax liability (in shares) |
|
(7,000)
|
|
|
|
| Common stock redeemed for tax liability |
(583)
|
|
(583)
|
|
|
| Other comprehensive (loss) gain, net of tax |
(185)
|
|
|
(185)
|
|
| Net income |
51,690
|
|
|
|
51,690
|
| Ending balance (in shares) at Sep. 26, 2024 |
|
107,224,000
|
|
|
|
| Ending balance at Sep. 26, 2024 |
$ 2,111,055
|
$ 107
|
536,238
|
(79)
|
1,574,789
|
| Beginning balance (in shares) at Dec. 26, 2024 |
107,356,999
|
107,357,000
|
|
|
|
| Beginning balance at Dec. 26, 2024 |
$ 2,170,158
|
$ 107
|
547,818
|
(40)
|
1,622,273
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Stock-based compensation expense |
6,580
|
|
6,580
|
|
|
| Exercise of stock options (in shares) |
|
50,000
|
|
|
|
| Exercise of stock options |
1,288
|
|
1,288
|
|
|
| Issuance of common stock upon vesting of restricted stock units (in shares) |
|
247,000
|
|
|
|
| Issuance of common stock upon vesting of restricted stock units |
0
|
$ 1
|
(1)
|
|
|
| Shares issued under employee stock purchase plan (in shares) |
|
36,000
|
|
|
|
| Shares issued under employee stock purchase plan |
3,081
|
|
3,081
|
|
|
| Common stock redeemed for tax liability (in shares) |
|
(84,000)
|
|
|
|
| Common stock redeemed for tax liability |
(8,212)
|
|
(8,212)
|
|
|
| Other comprehensive (loss) gain, net of tax |
(10)
|
|
|
(10)
|
|
| Net income |
48,878
|
|
|
|
48,878
|
| Ending balance (in shares) at Mar. 27, 2025 |
|
107,606,000
|
|
|
|
| Ending balance at Mar. 27, 2025 |
$ 2,221,763
|
$ 108
|
550,554
|
(50)
|
1,671,151
|
| Beginning balance (in shares) at Dec. 26, 2024 |
107,356,999
|
107,357,000
|
|
|
|
| Beginning balance at Dec. 26, 2024 |
$ 2,170,158
|
$ 107
|
547,818
|
(40)
|
1,622,273
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Exercise of stock options (in shares) |
132,665
|
|
|
|
|
| Other comprehensive (loss) gain, net of tax |
$ 35
|
|
|
|
|
| Net income |
$ 169,316
|
|
|
|
|
| Ending balance (in shares) at Sep. 25, 2025 |
107,745,936
|
107,746,000
|
|
|
|
| Ending balance at Sep. 25, 2025 |
$ 2,362,150
|
$ 108
|
570,458
|
(5)
|
1,791,589
|
| Beginning balance (in shares) at Mar. 27, 2025 |
|
107,606,000
|
|
|
|
| Beginning balance at Mar. 27, 2025 |
2,221,763
|
$ 108
|
550,554
|
(50)
|
1,671,151
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Stock-based compensation expense |
8,922
|
|
8,922
|
|
|
| Exercise of stock options (in shares) |
|
23,000
|
|
|
|
| Exercise of stock options |
754
|
|
754
|
|
|
| Issuance of common stock upon vesting of restricted stock units (in shares) |
|
12,000
|
|
|
|
| Common stock redeemed for tax liability (in shares) |
|
(3,000)
|
|
|
|
| Common stock redeemed for tax liability |
(296)
|
|
(296)
|
|
|
| Other comprehensive (loss) gain, net of tax |
21
|
|
|
21
|
|
| Net income |
63,178
|
|
|
|
63,178
|
| Ending balance (in shares) at Jun. 26, 2025 |
|
107,638,000
|
|
|
|
| Ending balance at Jun. 26, 2025 |
2,294,342
|
$ 108
|
559,934
|
(29)
|
1,734,329
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Stock-based compensation expense |
6,870
|
|
6,870
|
|
|
| Exercise of stock options (in shares) |
|
60,000
|
|
|
|
| Exercise of stock options |
1,019
|
|
1,019
|
|
|
| Issuance of common stock upon vesting of restricted stock units (in shares) |
|
10,000
|
|
|
|
| Shares issued under employee stock purchase plan (in shares) |
|
42,000
|
|
|
|
| Shares issued under employee stock purchase plan |
2,889
|
|
2,889
|
|
|
| Common stock redeemed for tax liability (in shares) |
|
(4,000)
|
|
|
|
| Common stock redeemed for tax liability |
(254)
|
|
(254)
|
|
|
| Other comprehensive (loss) gain, net of tax |
24
|
|
|
24
|
|
| Net income |
$ 57,260
|
|
|
|
57,260
|
| Ending balance (in shares) at Sep. 25, 2025 |
107,745,936
|
107,746,000
|
|
|
|
| Ending balance at Sep. 25, 2025 |
$ 2,362,150
|
$ 108
|
$ 570,458
|
$ (5)
|
$ 1,791,589
|